Zipper-interacting protein kinase is involved in regulation of ubiquitination of the androgen receptor, thereby contributing to dynamic transcription complex assembly

Oncogene

Volumn 32, Issue 41, 2013, Pages 4981-4988

  Felten, A ^a   Brinckmann, D ^a,b   Landsberg, G ^a   Scheidtmann, K H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b SoITbe IT Solutions   (Germany)

Author keywords

AATF Che 1; AR; Mdm2; TSG101; ubiquitination; ZIPK

Indexed keywords

ANDROGEN RECEPTOR; APOPTOSIS ANTAGONIZING TRANSCRIPTION FACTOR; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; PROSTATE SPECIFIC ANTIGEN; PROTEASOME; PROTEIN MDM2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNCLASSIFIED DRUG; ZIPPER INTERACTING PROTEIN KINASE;

AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; ENHANCER REGION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE SPECIFIC ANTIGEN GENE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANDROGENS; APOPTOSIS REGULATORY PROTEINS; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; MAP KINASE KINASE KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTORS, ANDROGEN; REGULATORY ELEMENTS, TRANSCRIPTIONAL; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; UBIQUITINATION;

EID: 84885648093     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.503     Document Type: Article

References (40)

1. Heemers HV, Tindall DJ. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 2007; 28: 778-808. (Pubitemid 350294296)
2. Faus H, Haendler B. Post-translational modifications of steroid receptors. Biomed Pharmacother 2006; 60: 520-528.
3. Gioeli D, Paschal BM. Post-translational modification of the androgen receptor. Mol Cell Endocrinol 2012; 352: 70-78.
4. Hinojos CA, Sharp ZD, Mancini MA. Molecular dynamics and nuclear receptor function. Trends Endocrinol Metab 2005; 16: 12-18. (Pubitemid 40037722)
5. Johnsen SA, Kangaspeska S, Reidt G, Gannon F. Interfering with the dynamics of estrogen receptor-regulated transcription. Ernst Schering Found Symp Proc 2006; 1: 1-12.
6. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000; 103: 843-852.
7. Reid G, Hubner MR, Métivier R, Brand H, Denger S, Manu D et al. Cyclic, protea-some-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 2003; 11: 695-707. (Pubitemid 36385123)
8. Métivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003; 115: 751-763. (Pubitemid 38030303)
9. Wang Q, Carroll JS, Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 2005; 19: 631-642. (Pubitemid 41219439)
10. Kang Z, Pirskanen A, Janne OA, Palvimo JJ. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 2002; 277: 48366-48371. (Pubitemid 35470792)
11. Kang Z, Janne OA, Palvimo JJ. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol 2004; 18: 2633-2648. (Pubitemid 39482054)
12. Welsbie DS, Xu J, Chen Y, Borsu L, Scher HI, Rosen N et al. Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer. Cancer Res 2009; 69: 958-966.
13. Keppler BR, Archer TK, Kinyamu HK. Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription. Biochim Biophys Acta 2011; 1809: 109-118.
14. Gaughan L, Logan IR, Neal DE, Robson CN. Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res 2005; 33: 13-26. (Pubitemid 40276925)
15. Xu K, Shimelis H, Linn DE, Jiang R, Yang X, Sun F et al. Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell 2009; 15: 270-282.
16. Leister P, Burgdorf S, Scheidtmann KH. Apoptosis antagonizing transcription factor AATF is a novel co-activator of nuclear hormone receptors. Signal Trans-duction 2003; 3: 17-25. (Pubitemid 37392181)
17. Burgdorf S, Leister P, Scheidtmann KH. TSG101 interacts with apoptosis-antag-onizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination. J Biol Chem 2004; 279: 17524-17534. (Pubitemid 38560516)
18. Leister P, Felten A, Chasan AI, Scheidtmann KH. ZIP kinase plays a crucial role in androgen receptor-mediated transcription. Oncogene 2008; 27: 3292-3300. (Pubitemid 351733394)
19. Page G, Lodige I, Kogel D, Scheidtmann KH. AATF, a novel transcription factor that interacts with Dlk/ZIP kinase and interferes with apoptosis. FEBS Lett 1999b; 462: 187-191.
20. Passananti C, Floridi A, Fanciulli M. Che-1/AATF, a multivalent adaptor connecting transcriptional regulation, checkpoint control, and apoptosis. Biochem Cell Biol 2007; 85: 477-483. (Pubitemid 47518042)
21. Bruno T, De Angelis R, De Nicola F, Barbato C, Di Padova M, Corbi N et al. Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb. Cancer Cell 2002; 2: 387-399. (Pubitemid 41039105)
22. Di Padova M, Bruno T, De Nicola F, Iezzi S, D'Angelo C, Gallo R et al. Che-1 arrests human colon carcinoma cell proliferation by displacing HDAC1 from the p21WAF1/CIP1 promoter. J Biol Chem 2003; 278: 36496-36504. (Pubitemid 37139979)
23. Scheidtmann KH. Dlk/ZIP kinase, a novel Ser/Thr-specific protein kinase with multiple functions. Signal Transduction 2007; 7: 248-259. (Pubitemid 47051576)
24. Brognard J, Zhang YW, Puto LA, Hunter T. Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinase. Cancer Res 2011; 71: 3152-3161.
25. Bi J, Lau SH, Hu L, Rao HL, Liu HB, Zhan WH et al. Downregulation of ZIP kinase is associated with tumor invasion, metastasis and poor prognosis in gastric cancer. Int J Cancer 2009; 124: 1587-1593.
26. Natrajan R, Mackay A, Lambros MB, Weigelt B, Wilkerson PM, Manie E et al. A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and-positive breast cancers. J Pathol 2012; 227: 29-41.
27. Kawai T, Matsumoto M, Takeda K, Sanjo H, Akira S. ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol Cell Biol 1998; 18: 1642-1651. (Pubitemid 28100930)
28. Sato N, Kawai T, Sugiyama K, Muromoto R, Imoto S, Sekine Y et al. Physical and functional interactions between STAT3 and ZIP kinase. Int Immunol 2005; 17: 1543-1552. (Pubitemid 41754677)
29. Engemann H, Heinzel V, Page G, Preuss U, Scheidtmann KH. DAP-like kinase interacts with the rat homolog of Schizosaccharomyces pombe CDC5 protein, a factor involved in pre-mRNA splicing and required for G2/M phase transition. Nucleic Acids Res 2002; 30: 1408-1417. (Pubitemid 34679720)
30. De Nicola F, Bruno T, Iezzi S, Di Padova M, Floridi A, Passananti C et al. The prolyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage. J Biol Chem 2007; 282: 19685-19691. (Pubitemid 47100057)
31. Li L, Liao J, Ruland J, Mak TW, Cohen SNA. TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc Natl Acad Sci USA 2001; 98: 1619-1624. (Pubitemid 32165548)
32. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. Phosphorylation-dependent ubi-quitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 2002b; 21: 4037-4048. (Pubitemid 34857436)
33. Burch LR, Scott M, Pohler E, Meek D, Hupp T. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1. J Mol Biol 2004; 337: 115-128. (Pubitemid 38292047)
34. Saji S, Okumura N, Eguchi H, Nakashima S, Suzuki A, Toi M et al. MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells. Biochem Biophys Res Commun 2001; 281: 259-265. (Pubitemid 32924428)
35. Sharma D, Fondell JD. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc Natl Acad Sci USA 2002; 99: 7934-7939. (Pubitemid 34650983)
36. Vaisanen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha, 25-dihydroxyvitamin D3. J Mol Biol 2005; 350: 65-77. (Pubitemid 40804732)
37. Lin HK, Altuwaijri S, Lin WJ, Kan PY, Collins LL, Chang C. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J Biol Chem 2002a; 277: 36570-36576.
38. Chymkowitch P, Le May N, Charneau P, Compe E, Egly JM. The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process. EMBO J 2011; 30: 468-479.
39. Graves PR, Winkfield KM, Haystead TA. Regulation of zipper-interacting protein kinase activity in vitro and in vivo by multisite phosphorylation. J Biol Chem 2005; 280: 9363-9374. (Pubitemid 40409630)
40. Felten A, Leister P, Burgdorf S, Uhlmann L, Scheidtmann KH. Characterization of rat BLOS2/Ceap, a putative yeast She3 homolog, as interaction partner of apoptosis antagonizing transcription factor/Che-1. Biol Chem 2007; 388: 569-582. (Pubitemid 46883452)